The platform is adopted by healthcare providers and research organisations for its integration with their current lab information systems. Credit: PeopleImages.com – Yuri A/Shutterstock.

该平台因其与当前实验室信息系统的集成而被医疗保健提供者和研究机构采用。图片来源：PeopleImages.com – Yuri A/Shutterstock。

US-based Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology platform.

总部位于美国的 Gestalt Diagnostics 已完成 A 轮融资，筹集了 750 万美元用于扩展其 AI 驱动的 PathFlow 病理学平台。

The funding will also enable wider market adoption and platform profitability.

资金还将有助于更广泛的市场应用和平台盈利。

Go deeper with GlobalData

深入挖掘GlobalData

Reports

报告

Artificial Intelligence in Healthcare: Digital Pathology

医疗保健中的人工智能：数字病理学

Reports

报告

Artificial Intelligence in Healthcare: Digital Pathology Guided Rob...

医疗保健中的人工智能：数字病理引导的机器人...

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

TVF Funds, Inland Imaging Investments, Cowles Ventures and KickStart Funds led the financing round, which included participation from Pacific Northwest investors.

TVF基金、内陆影像投资、考尔斯创投和KickStart基金领投了本轮，太平洋西北地区的投资者也参与其中。

The capital injection will be used to widen the company’s customer base, improve its AI offerings, and help enable clearance from the US Food and Drug Administration (FDA).

这笔资金注入将被用于扩大公司的客户群、改进其人工智能产品，并帮助获得美国食品药品监督管理局 (FDA) 的批准。

PathFlow is adopted by healthcare providers, research organisations and academic medical centres for its integration with their current lab information systems.

PathFlow 被医疗保健提供者、研究机构和学术医疗中心采用，因为它能与他们当前的实验室信息系统集成。

This integration expedites diagnoses and enhances access to consultation, research and education, irrespective of the location.

这种整合加快了诊断速度，并增强了获取咨询、研究和教育的机会，不受地点限制。

GlobalData Strategic Intelligence

全球数据战略情报

US Tariffs are shifting - will you react or anticipate?

美国关税正在变化——你会做出反应还是提前预料？

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。

By GlobalData

由GlobalData提供

Learn more about Strategic Intelligence

了解有关战略情报的更多信息

According to Gestalt, the platform not only accelerates the processes crucial for cancer patients awaiting diagnoses but also offers AI-powered insights.

根据 Gestalt 的说法，该平台不仅加速了癌症患者等待诊断的关键过程，还提供了人工智能驱动的见解。

These insights facilitate biomarker scoring for patient-therapy matching.

这些见解有助于患者治疗匹配的生物标志物评分。

They also enable analysis of images and data for disease progression studies and provide pathologists with valuable aids that streamline workflows and decrease diagnostic errors.

它们还能够对图像和数据进行分析，用于疾病进展研究，并为病理学家提供有价值的辅助工具，简化工作流程并减少诊断错误。

Gestalt’s PathFlow V5.0 employs several latest features, including the capability to conduct AI-based image analysis using various AI partners simultaneously.

Gestalt公司的PathFlow V5.0采用了多项最新功能，包括能够同时使用不同的AI合作伙伴进行基于人工智能的图像分析。

The outcomes can be retrieved and displayed on PathFlow’s viewer. On demand, the data from various algorithms can be switched.

结果可以检索并显示在PathFlow的查看器上。根据需要，可以切换来自不同算法的数据。

The platform also includes secure e-signature capabilities for report sign-out through digital signature provider DocuSign and also has a Voicebrook integration.

该平台还通过数字签名提供商DocuSign提供安全的电子签名功能以完成报告签出，并且还集成了Voicebrook。

It facilitates automatic upload of digital assets directly to cases.

它能够自动将数字资产直接上传到案件中。

Gestalt Diagnostics CEO Dan Roark said: “PathFlow is transforming pathology by leveraging robust digital workflows and AI algorithms to support scoring of key biomarkers. This enables organisations to accurately match patients to known therapies and generate rich datasets for research and new drug development..

Gestalt Diagnostics 首席执行官丹·罗克表示：“PathFlow 正在通过利用强大的数字工作流程和人工智能算法来支持关键生物标志物的评分，从而变革病理学。这使组织能够准确地将患者与已知疗法相匹配，并生成用于研究和新药开发的丰富数据集。”

“Our technology is designed to improve patient outcomes by enabling faster, more accurate diagnoses and broadening access to clinical expertise.”

“我们的技术旨在通过实现更快、更准确的诊断并拓宽临床专业知识的获取途径来改善患者的治疗效果。”

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

利用我们领先的行业洞察，为您的业务提供优势。

Sign up

注册

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到Facebook